Search alternatives:
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
b decrease » b1 decreased (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
16 b » 16 _ (Expand Search), 1 b (Expand Search), 6 b (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
b decrease » b1 decreased (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
16 b » 16 _ (Expand Search), 1 b (Expand Search), 6 b (Expand Search)
-
1
Mean change in incidence and diagnoses if testing rates decrease.
Published 2013“…<p>Change in incidence (A) and diagnoses (B) if testing rates decrease by 30% and 50% relative to the current testing rate.…”
-
2
-
3
-
4
WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription.
Published 2013“…<p>(<i>A</i>) WNT3 decreased proliferation of GCPs by 40.3± 5.0% of the control (Con) (n=3) as measured by [<sup>3</sup>H]-Thymidine incorporation assay. …”
-
5
-
6
-
7
-
8
-
9
Translocation of EHEC-Hly to mitochondria results in cytosolic cytochrome c release and ΔΨ<sub>m</sub> decrease.
Published 2013“…<p>(<b>A, B</b>) HBMEC (<b>A</b>) and Caco-2 cells (<b>B</b>) were incubated for the times indicated with EHEC-Hly-containing OMVs TA50 or 8033 (20 µg of OMV protein containing 100 ng of EHEC-Hly) or with corresponding protein amounts of EHEC-Hly-negative OMVs TA51 or 8033c or left untreated (control). …”
-
10
-
11
-
12
-
13
-
14
-
15
-
16
Loperamide decreases mechanical responsiveness of unmyelinated, nociceptive C-fibers.
Published 2013“…Dashed line indicates threshold assigned to afferents unresponsive to 25 g vF hair. B) Loperamide dose-dependently decreases the responsiveness to suprathreshold mechanical stimuli in both animal groups (ANOVA lesion: F<sub>(3,35)</sub> = 10.3, p<0.001; ANOVA sham: F<sub>(3,16)</sub> = 4.5, p<0.05). …”
-
17
-
18
-
19
-
20
The frequency of decrease in UACR and UPCR at 16 weeks as secondary outcomes.
Published 2013“…Outcome Ba and Bp: frequency of decrease in UACR and UPCR ≥50% at 16 weeks compared to baseline level, Outcome Ca and Cp: frequency of decrease in UACR and UPCR <200 mg/g cr at 16 weeks. …”